NVIV - InVivo Therapeutics Holdings Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development10,37312,55710,05810,894
Selling General and Administrative13,32211,50612,3407,566
Non Recurring----
Total Operating Expenses23,69524,06322,39818,460
Operating Income or Loss-23,695-24,063-22,398-18,460
Income from Continuing Operations
Total Other Income/Expenses Net-3,050625-10,916114
Earnings Before Interest and Taxes-23,695-24,063-22,398-18,460
Interest Expense-74-155-172-136
Income Before Tax-26,745-23,438-33,314-18,346
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-26,745-23,438-33,314-18,346
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-26,745-23,438-33,314-18,346
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-26,745-23,438-33,314-18,346